Residual symptoms in moderate to severe COVID-19 patients

被引：0
|
作者：
Elfidha, Sabrine [1 ]
Louhaichi, Sabrine [1 ]
Khalfallah, Ikbel [1 ]
Marzouki, Safa [1 ]
Kaabi, Line [1 ]
Jebeli, Rihab [1 ]
Kharrat, Mohamed Ali [1 ]
Ammar, Jamel [1 ]
Hamdi, Besma [1 ]
Hamzaoui, Agnes [1 ]
机构：
[1] Pneumol, Tunis, Tunisia
来源：
EUROPEAN RESPIRATORY JOURNAL | 2021年 / 58卷
关键词：
Covid-19; Quality of life; Cough;
D O I：
10.1183/13993003.congress-2021.PA3485
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA3485
引用
收藏
页数：2
相关论文
共 50 条
  • [31] High incidence of venous thrombosis in patients with moderate-to-severe COVID-19
    Oleg Kerbikov
    Pavel Orekhov
    Ekaterina Borskaya
    Natalia Nosenko
    [J]. International Journal of Hematology, 2021, 113 : 344 - 347
  • [32] Tocilizumab use in patients with moderate to severe COVID-19: A retrospective cohort study
    Chilimuri, Sridhar
    Sun, Haozhe
    Alemam, Ahmed
    Kang, Kyoung-Sil
    Lao, Peter
    Mantri, Nikhitha
    Schiller, Lawrence
    Sharabun, Myroslava
    Shehi, Elona
    Tejada, Jairo
    Yugay, Alla
    Nayudu, Suresh Kumar
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (02) : 440 - 446
  • [33] Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial
    Darazam, Ilad Alavi
    Shokouhi, Shervin
    Mardani, Masoud
    Pourhoseingholi, Mohamad Amin
    Rabiei, Mohammad Mahdi
    Hatami, Firouze
    Shabani, Minoosh
    Moradi, Omid
    Gharehbagh, Farid Javandoust
    Irvani, Seyed Sina Naghibi
    Amirdosara, Mahdi
    Hajiesmaeili, Mohammadreza
    Rezaei, Omidvar
    Khoshkar, Ali
    Lotfollahi, Legha
    Gachkar, Latif
    Dehbsneh, Hadiseh Shabanpour
    Khalili, Negar
    Soleymaninia, Azam
    Kusha, Akram Hoseyni
    Shoushtari, Maryam Taleb
    Torabinavid, Parham
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 99
  • [34] ABCD Mnemonic in moderate to severe COVID-19 management
    Ahuja, Vanita
    Mahajan, Aastika
    Bevoor, Arun A.
    [J]. JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY, 2022, 38 : 153 - 154
  • [35] Evaluation of oxidative stress markers in hospitalized patients with moderate and severe COVID-19
    Zendelovska, Dragica
    Atanasovska, Emilija
    Petrushevska, Marija
    Spasovska, Katerina
    Stevanovikj, Milena
    Demiri, Ilir
    Labachevski, Nikola
    [J]. ROMANIAN JOURNAL OF INTERNAL MEDICINE, 2021, 59 (04) : 375 - 383
  • [36] Intravascular volume status in patients with moderate to severe COVID-19: a case series
    Akbari, Hamideh
    Safaei, Arash
    Akhgar, Atousa
    [J]. FRONTIERS IN EMERGENCY MEDICINE, 2024, 8 (03):
  • [37] ABCD Mnemonic in moderate to severe COVID-19 management
    Ahuja, Vanita
    Mahajan, Aastika
    Bevoor, Arun A.
    [J]. JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY, 2022, 38 (05) : 153 - 154
  • [38] Descriptive characteristics of continuous oximetry measurement in moderate to severe covid-19 patients
    Jonathan A. Sobel
    Jeremy Levy
    Ronit Almog
    Anat Reiner-Benaim
    Asaf Miller
    Danny Eytan
    Joachim A. Behar
    [J]. Scientific Reports, 13 (1)
  • [39] USE OF BARICITINIB AND TOCILIZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE COVID-19 IN HOSPITALIZED PATIENTS
    Xibille Friedmann, D. X.
    Carrillo Vazquez, S. M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 899 - 900
  • [40] Infliximab Concentrations in Participants with Moderate to Severe COVID-19
    Balevic, Stephen J.
    Dandachi, Dima
    Dixon, Danielle
    Hoetelmans, Richard M. W.
    Bozzette, Sam
    Mccarthy, Matthew W.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (04): : 490 - 491
12345